Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes
U Neogi, K Singh, SG Aralaguppe, LC Rogers… - Aids, 2018 - journals.lww.com
Objective: To determine the antiretroviral activity of the integrase strand transfer inhibitors
(INSTIs), raltegravir (RAL), elvitegravir (EVG), dolutegravir (DTG), cabotegravir (CAB) and …
(INSTIs), raltegravir (RAL), elvitegravir (EVG), dolutegravir (DTG), cabotegravir (CAB) and …
Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes.
U Neogi, K Singh, SG Aralaguppe… - AIDS (London …, 2018 - europepmc.org
Objective To determine the antiretroviral activity of the integrase strand transfer inhibitors
(INSTIs), raltegravir (RAL), elvitegravir (EVG), dolutegravir (DTG), cabotegravir (CAB) and …
(INSTIs), raltegravir (RAL), elvitegravir (EVG), dolutegravir (DTG), cabotegravir (CAB) and …
[HTML][HTML] Ex vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV-1 non-B subtypes
U NEOGI, K SINGH, SG ARALAGUPPE… - AIDS (London …, 2018 - ncbi.nlm.nih.gov
Objective To determine the antiretroviral activity of the integrase strand transfer inhibitors
(INSTIs), raltegravir, elvitegravir, dolutegravir, cabotegravir and bictegravir, against different …
(INSTIs), raltegravir, elvitegravir, dolutegravir, cabotegravir and bictegravir, against different …
Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes
U Neogi, K Singh, SG Aralaguppe… - AIDS (London …, 2018 - pubmed.ncbi.nlm.nih.gov
Objective To determine the antiretroviral activity of the integrase strand transfer inhibitors
(INSTIs), raltegravir (RAL), elvitegravir (EVG), dolutegravir (DTG), cabotegravir (CAB) and …
(INSTIs), raltegravir (RAL), elvitegravir (EVG), dolutegravir (DTG), cabotegravir (CAB) and …
Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes.
U Neogi, KS Kamalendra Singh, SG Aralaguppe… - 2018 - cabidigitallibrary.org
Objective: To determine the antiretroviral activity of the integrase strand transfer inhibitors
(INSTIs), raltegravir (RAL), elvitegravir (EVG), dolutegravir (DTG), cabotegravir (CAB) and …
(INSTIs), raltegravir (RAL), elvitegravir (EVG), dolutegravir (DTG), cabotegravir (CAB) and …